Estimates of familial risk of infl ammatory bowel diseases (IBDs), Crohn's disease (CD), and ulcerative colitis (UC) are needed for counseling of patients and could be used to target future prevention. We aimed to provide comprehensive population-based estimates of familial risk of IBD.
INTRODUCTION
Th e infl ammatory bowel diseases (IBDs) Crohn's disease (CD) and ulcerative colitis (UC) aff ect somewhere between 0.3 and 0.8% of the European population ( 1, 2 ) . CD and UC are chronic conditions characterized by recurrent episodes of bowel pain, discomfort, fatigue, and multiple putrid bloody stools ( 3 ) . Despite recent progress, treatment remains unsatisfactory as well as costly, and signifi cant disease-related morbidity is common ( 1 ) . IBD is believed to develop as a result of a combination of genetic and environmental factors. In recent years, genomewide association studies have identifi ed 163 loci associated with IBD, with a large proportion of shared loci between CD and UC ( 4 ) . In addition, among a number of suggested environmental factors, the gut microbiota has emerged as a potential etiological component in IBD. Th e microbiota could be a possible target for prevention of these diseases ( 5 ) , leading to the hope that preventive strategies will become accessible in a not so distant future. Relatives of IBD cases are obvious targets of such preventive measures.
Studies of familial risk in IBD have consistently reported increased risk of UC and CD in fi rst-degree relatives of aff ected IBD cases. However, the magnitude of the increased risk varies greatly between studies, due to markedly heterogeneous methodologies (6) (7) (8) (9) . Furthermore, data on distant family members, such as second-and third-degree relatives, are rare and from small materials (10) (11) (12) . Adding to that, a few smaller studies have suggested relatively lower age at diagnosis of IBD among children of IBD-aff ected parents, but this has been ascribed to ascertainment bias or period eff ects (12) (13) (14) . To use relatives of IBD patients for future preventive strategies, specifi c knowledge on the magnitude of familial risk, and the impact of age, is essential. Further, unbiased estimates of familial risk in UC and CD, including distant relatives, are essential for correct counsel of aff ected cases and their family members.
Th e aim of the present study was to conduct a comprehensive population-based study of unselected IBD patients to estimate the risk of CD or UC in relatives of patients with these diseases over a 35-year period. Th e study covered all relatives from fi rst-to third-degree and further estimated the familial risk in diff erent age groups.
METHODS

Study cohort
All persons registered in the Danish Civil Registration system, alive in 1977 or born from 1977 to 2011, were included in the study cohort. Th e Danish civil registration system, founded in 1968, covers all citizens living in Denmark from 1968 to present date ( 15 ) . Th rough a unique personal identifi cation number assigned to each Dane, information is available on gender, date, location of birth, identity of parents, and updated information on vital status as well as emigration. Th e number also permits accurate linkage of individual-level information between the nationwide registries.
Identifi cation of IBD cases
IBD cases with either CD or UC were identifi ed using the Danish National Patients Register (NPR), which is a nationwide register of all operations and hospital discharge diagnoses recorded in Danish hospitals since 1977. Th e NPR provided data for the whole follow-up period from its establishment in 1977 to the end of the study, 31 December 2011. Th e register furthermore provides outpatient data from 1995 up until present date. Th e system is based on International Classifi cation of Disease codes. Cases were identifi ed using the 8th and 10th revision codes for CD (563.00-563.09 and K50) and UC (563.19, 569.04, and K51). Diagnoses of IBD in the NPR have previously been validated and were found to be correct in 90% of UC cases and 98% of CD cases ( 16 ) . However, in an attempt to further optimize the validity of diagnoses in the present study, we only included as cases those patients who had at least two independent recordings of IBD in NPR. If patients had received a diagnosis of UC and CD during their disease course, then the last diagnosis registered was regarded as valid, knowing that up to 10% of patients change diagnosis during follow-up. Th e date of diagnosis remained, however, the fi rst date of diagnosis of any IBD.
Assessing family ties
Data from the NPR were merged with data from the Danish Civil Registration system and the Danish Familial Relations Database. Th e Danish Familial Relations Database contains kinship information, even covering third-degree relatives in the most recent cohorts. Th e kinship information is retrieved from the Civil Registration system to identify mothers and fathers of a proband. In turn, this information can be used to identify siblings and half siblings, as well as more distant relatives, using the parental links of mothers and fathers ( 17, 18 ) . All individuals born in Denmark in 1968 or later have parental links, as a result of the construction of parental links, registration of grandparents is almost complete only for those children born in 1990 or later in Denmark. Th e identity of both parents has previously been estimated to be known for 48% of children in the cohort born abroad ( 19 ) .
We categorized the distinct types of relations into three groups, based on the expected percentage of shared genes. Th e groups were (i) fi rst-degree relatives: siblings (including twins), off spring, and parents, (ii) second-degree relatives: grandchildren, uncles, aunts, and (maternal and paternal) half siblings, as well as (iii) thirddegree relatives: half uncles and aunts, nephews, nieces, and cousins. Family members were regarded as exposed from the date of diagnosis of the fi rst aff ected case in the family. Th e second family member to become ill was regarded as the fi rst family case, and all remaining family members were regarded as exposed to two family cases from the date of diagnosis of the second case. As such any family member contracting IBD aft er emigration would not be registered.
Statistical analysis
Cohort members were followed from date of birth or 1 January 1977, whichever came latest and until death, emigration, a diagnosis of either CD alternatively UC, or end of follow-up on 31 December 2011, whichever came fi rst. Cohort members only contributed person-years to the cohort while at risk, i.e., being alive and living in Denmark.
Using Poisson regression, the incidence rate ratio (IRR) with 95% confi dence intervals (CI) of CD in relatives to CD cases was calculated, employing individuals with relatives of the same type without IBD as a reference group. As an example, the IRR for 'CD in children with aff ected mothers' was estimated as the rate of CD in persons with a CD-aff ected mother compared with the rate of CD in persons having only an unaff ected mother. Similar defi nitions were used for UC when assessing the risk of UC in UC relatives, for UC in CD relatives, and CD in UC relatives. Comparing individuals with the same type of familial relationship reduces bias due to incomplete registration of distant relatives in early birth cohorts ( 17 ) . A person was considered as exposed, from the date of diagnosis of any relative of a particular type linked to that person. IRRs were adjusted for age (5-year age intervals), gender, time period (5-year age intervals). Eff ect modifi cation by age was evaluated by including interaction terms between age and diff erent types of family history. Wald chi 2 test was used to estimate whether diff erences found between diff erent relation groups were significant. Age-specifi c prevalence was calculated as the proportion of persons with a known prior diagnosis of CD or UC, alive and living in Denmark at the end of 2011. Ten-year risk estimates were calculated as follows (ignoring competing risks): the age-specifi c INFLAMMATORY BOWEL DISEASE VOLUME 110 | APRIL 2015 10-year risks for individuals without family history were estimated as 1-exp(-Λ ), where Λ was the cumulative incidence estimated by age-specifi c (5-year groups) incidence rates using data from the period 2002-2011. Th e age-specifi c 10-year risks for individuals with a specifi c family history were estimated similarly but with incidence rate multiplied by the rate ratio for the specifi c family history (age-specifi c rate ratios were used for fi rst-degree relatives). Data were analyzed using SAS V.9.4 (SAS Institute, Cary, NC).
RESULTS
Out of 8,295,773 people, 45,857 persons received at least two diagnoses of CD or UC from 1977 until 2011. Using a conservative defi nition demanding at least two diagnoses to constitute an IBD case, the overall CD incidence was 7.6/100,000 personyears. Th e overall UC incidence was 15.0/100,000 person-years. Th e entire cohort was followed for ~200 million person-years with a mean follow-up time of 24 years. A total of 2,376,303 persons were born into the cohort, 2,058,395 persons died and 589,621 persons emigrated during the study period. For further details on follow-up time, see Supplementary Table 1 online.
Th e overall proportion of IBD cases with a positive family history amounted to 6.6% of all CD cases and 4.8% of all UC cases. However, due to the design the proportion of new IBD cases with a positive family history increased throughout the study period. In the most recent cohort from 2007 to 2011, the proportion of new CD cases with a positive family history reached 12.2%, the proportion of UC cases from the same period with a positive family history accounted for 8.8% ( Supplementary Tables 2-5 ). Among CD cases with a positive family history, 72% had a fi rstdegree relative, 23% a second-, and 5% a third-degree relative with IBD. Among UC cases with a positive family history, 77% had a fi rst-degree relative, 19% a second-, and 4% a third-degree relative with IBD.
Risk of IBD with one IBD relative
Th e IRR of CD was signifi cantly increased in fi rst-degree relatives (IRR; 7.77; 95% CI, 7.05-8.56), second-degree relatives (IRR, 2.44; 95% CI, 2.01-2.96), and third-degree relatives (IRR, 1.88; 95% CI, 1.30-2.71), as compared with relatives of the same type without IBD. Crude estimates were slightly higher than estimates adjusted for age, gender, and time period ( Figure 1 ) .
Th e IRR of UC was also signifi cantly increased in fi rst-degree relatives (IRR, 4.08; 95% CI, 3.81-4.38), second-degree relatives (IRR, 1.85; 95% CI, 1.60-2.13), and third-degree relatives (IRR, 1.51; 95% CI, 1.07-2.12) in comparison with relatives of the same type without IBD ( Figure 2 ).
Figures 1 and 2 also present the risk of IBD in fi rst-degree relatives according to specifi c type of relation (twin, sibling, mother, father, and off spring), using ad reference relatives of the same type without IBD. Th e highest IRRs were found in twins with a CD co-twin (IRR; 51.40; 95% CI, 29.12-90.71) or a UC co-twin (IRR, 11.29; 95%CI, 6.18-20.61). IRRs for family history in siblings, mothers, and fathers were similar to the overall fi rst-degree estimates. Th e IRR of CD in parents to CD-aff ected off spring was slightly lower than for other fi rst-degree relatives (IRR, 5.52; 95% CI, 4.43-6.88), as was the IRR for UC in parents to off spring with UC (IRR, 3.05; 95% CI, 2.64-3.54).
Adjusted risk estimates for family history in uncles, aunts, nephews, nieces, grandchildren, and grandparents did not stand out from the overall second-degree familial risk estimates. Th e diff erent estimates for maternal and paternal half siblings did, however, warrant attention, though not signifi cantly diff erent. Risk of CD in half siblings to CD cases through fathers proved non-signifi cant 1.72 (95% CI, 0.82-3.64) as opposed to the risk of half siblings to UC cases through mothers; IRR for CD of 3.58 (95% CI, 1.98-6.57). Likewise, risk of UC in half siblings to UC cases through fathers proved non-signifi cant 1.68 (95% CI, 0.93-3.01) while half siblings to UC cases through mothers yielded the highest IRR for UC in second-degree relatives; 3.75 (95% CI, 2.29-6.16).
Risk of IBD with more than one IBD relative
Among individuals who had more than one IBD-aff ected relative, the risk of IBD was particularly high ( Figure 3 ). In individuals with more than one fi rst-degree relative, aff ected by IBD, the IRR of UC was 6.63 (95% CI, 5.02-8.75) and the IRR of CD was 9.77 (95% CI, 7.07-13.50). In individuals with more than one seconddegree relative, aff ected by IBD, the IRR of UC was 2.47 (95% CI, 1.51-4.05) and the IRR of CD was 3.31 (95% CI, 2.05-5.33).
Risk of UC with one CD relative and vice versa
A total of 20.5% of families with two or more aff ected members were pure CD families, 43.4% were pure UC families, and 36.1% were mixed CD and UC families ( Supplementary Table 8 ). Having a fi rst-degree relative with UC led to an IRR for CD of 2.84 (95% CI, 2.53-3.18) compared with family members of the same type without IBD. Correspondingly having a fi rst-degree relative with CD resulted in an IRR for UC of 2.60 (95% CI, 2.31-2.93). Th e same pattern, although less pronounced, was observed for second-degree relatives, whereas the two estimates for thirddegree relatives were based on too few observations to be evaluated ( Supplementary Figure 4 ) .
Age-specifi c IBD risks
Risk of CD and UC in fi rst-degree relatives of cases was modifi ed by age, with an increased familial risk in the younger age groups ( Figure 4 ). For second-degree relatives ( Supplementary  Figure 1 ) , we were not able to fi nd such an eff ect. Th ere were too few events among third-degree relatives to accurately assess whether such an eff ect modifi cation was present. A similar eff ect modifi cation was observed in individuals with siblings, fathers, and mothers suff ering from CD or UC, and was slightly less pronounced in individuals with off spring aff ected by CD or UC. Exemplifi ed by IRRs for family history in siblings, the pattern was similar when including only individuals born aft er 1972 (i.e., most likely to have a fully registered fi rst-degree family history); see Supplementary Figure 2 .
In the most recent cohorts, the proportion of new CD cases spanned from 7% in persons aged ≥60 to >20% in persons aged
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Prevalence and absolute risks
Th e presented IRR was refl ected in the point prevalence among persons aged 40 by the end of 2011. Persons without IBD relatives had a CD prevalence of 0.25% and a UC prevalence of 0.35%. Among relatives of CD cases, 2.63% of fi rst-degree relatives, 3.38% of siblings, 2.68% of mothers, 1.77% of fathers, 1.10% of second-degree relatives, and 0.75% of third-degree relatives had CD. Among relatives of UC cases 2.09% of fi rst-degree relatives, 3.01% of siblings, 1.62% of mothers, 2.07% of fathers, 0.59% of second-degree relatives, and 0.58% of third-degree relatives had UC ( Supplementary Table 9 ). We also calculated absolute risk for developing CD and UC. Table 1 shows the predicted risk in % of contracting CD or UC within 10 years by current age and family history. Predicted risk for a 10-year period was as high as 2% for CD and 3% for UC, in certain age groups among fi rst-degree family members of aff ected cases ( Table 1 ) .
Sensitivity analysis
To address how sensitive results were to the case defi nition and to allow for comparison with other studies, we performed a number of further sensitivity analyses. Using only hospitalized cases (i.e., not using outpatients registered from 1994 and onward), resulted in slightly higher estimates. Accepting the fi rst diagnosis as valid, instead of the most recent diagnosis, resulted in slightly reduced CD IRR estimates for relatives of CD cases, and UC IRR for UC relatives ( Supplementary  Figures 3-8 ). In contrast, CD IRR estimates for UC relatives and UC IRR estimates for CD relatives were increased. Reducing the number of contacts to qualify as an IBD case also resulted in slightly lower risk estimates.
DISCUSSION
Th is study provides comprehensive population-based familial risk estimates for IBD. Overall, up to 12% of CD patients and 9% of UC patients have a family history of IBD. Compared with families with no IBD history, the risk of CD in fi rst-degree relatives of a CD case was almost 8-fold increased, whereas the risk of UC in fi rst-degree relatives of a UC case was 4-fold increased. Th e resulting absolute risks exceeded 2% in both UC and CD over a 10-year period among younger fi rst-degree family members of aff ected cases. Th e risk was also signifi cantly increased in second-and third-degree relatives for UC as well as CD, although it was lower with lower degree of genetic relation. Having a relative with UC also increased the risk of CD and vice versa with 1/3 of families with 2 or more IBD-aff ected fi rst-degree relatives was particularly pronounced in younger individuals. Th e present estimates of the risk of IBD in family members were derived from a nationwide cohort, exceeding 45,000 IBD families being mixed CD/UC families. Th e increased IRR in individuals belonging to IBD-aff ected families was most prominent in twins and in individuals with more than two aff ected family members. Finally, the increase in IRR of IBD among 
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cases, and included distant relatives. Direct comparison with former studies is complicated by marked diff erences in study design. To our knowledge, only one contemporary population-based study on familial risk of IBD is available ( 6 ) . Th is Swedish study focused on IBD and a broad range of other autoimmune diseases, assessed familial risk in fi rst-degree relatives only, did not include IBD outpatients, and demanded only one diagnosis (the fi rst) to defi ne a case. Th ese diff erences in case defi nitions may explain why CD risk estimates were slightly lower, and UC risk estimates slightly higher than those observed in the present study. 
Strengths and limitations
Th e data presented here derive from a large well-defi ned population with nationwide coverage and complete follow-up. Th ough the validity of IBD diagnoses in the NPR is high ( 16 ) , at least two contacts to the health-care system resulting in an IBD diagnosis were demanded in our main analysis. Also, if cases had received a diagnosis of UC and CD during their disease course, then the last diagnosis registered was regarded as valid. We employed several sensitivity analyses to assess the validity of our case defi nitions. In one analysis, the fi rst diagnosis was allowed to count as the fi nal diagnosis, and only one contact with the system demanded to qualify as an IBD case, corres ponding to a newly diagnosed patient in a clinical setting. Th is analysis, as mentioned above, was similar to the Swedish case defi nition and resulted in slightly lower estimates for CD and similar UC estimates. A strength of the study was the inclusion of outpatient data from year 1994 resulting in a more complete material than that of former studies in the fi eld. However, it may potentially infl uence the observed diff erences in proportion of family cases over time, if IBD cases with a family history were more or less likely to be treated in an outpatient clinic or to become hospitalized than IBD patients without a family history. Reassuringly, excluding information on outpatients resulted in only slightly altered estimates, which could not explain observed diff erences in period estimates ( Supplementary Figures 3-8 ) .
A potential limitation of the study was incomplete registration that may arise in a cohort-based family study using record linkage. In our study, incomplete registration may occur in persons diagnosed with IBD before 1977, or persons with limited information on family ties in the earliest cohorts. Th is was illustrated by the lower proportion of cases with a family history of IBD in earlier cohorts. On the other hand, IRR estimates in diseases, such as IBD, with a prevalence of below 1%, are not markedly infl uenced by incomplete registration ( 26 ) . Accordingly, a sensitivity analysis including only persons born aft er 1972 (i.e., most likely to have fully registered fi rst-degree family relations) did not alter age stratifi ed estimates markedly (assessed for siblings only Supplementary Figure 2 ).
In conclusion, this large-scale population-based study provides novel information on familial risk of IBD, usable for researchers and clinicians alike. IBD aggregates in families, with up to 12% of CD cases and 9% of UC cases occurring in families already aff ected by IBD. Compared with families without an IBD history, the risk of CD in fi rst-degree relatives of a CD case is almost 8-fold increased, whereas the risk of UC in fi rst-degree relatives of a UC case is 4-fold increased. Th is results in absolute risks of more than 2% over 10 years in certain age groups among family members of fi rst-degree CD and UC cases. Familial risk estimates were lower with lower degree of genetic relation, but high enough to warrant clinical attention. Conversely, twins with aff ected co-twins as well as individuals with more than two aff ected family members were at high risk of contracting IBD. Family cases appeared to have a particularly high risk of IBD in early life, suggesting a role of a shared environment in addition to shared genes in familial aggregation of IBD. Th us, relatives of IBD-aff ected relatives could be a target for future prevention studies in IBD.
In contrast, former Danish studies have suggested an even higher risk focusing specifi cally on off spring of aff ected parents ( 8, 12 ) . Th e higher risk may in part be explained by the use of indirect calculations of familial risk, and a 20-year shorter follow-up time, potentially resulting in a selection toward younger ages, was-in the present study-we observed IRRs to be higher.
Th e overall proportion of family cases amounted to 4.8% of all UC cases and 6.6% of all CD cases in the present study, which appeared similar to 5.4% and 6.5% observed in the Swedish study ( 6 ) . However, this crude approach may underestimate the true proportion of family cases, as family ties are assumed to be less completely registered in earlier birth cohorts. Using only the most recent time periods with complete birth cohorts, we observed that up to 12% of all CD cases and close to 9% of all UC were family cases, with an even higher proportion of family cases in the younger age groups.
Th e crude proportion of family cases originating from secondand third-degree relatives was similar to earlier reports (10) (11) (12) . Apart from crude proportions, this study provides novel estimates the IBD risk in second-and third-degree relatives of IBD-aff ected cases.
Th e increase in IRR of IBD among fi rst-degree relatives was particularly pronounced in younger individuals. Previous fi ndings have been confl icting, spanning from claiming that generational diff erences are due to genetic anticipation ( 20 ) , over reporting a higher prevalence of a positive family history in pediatric IBD ( 9 ) and in younger age groups ( 12 ) , to explaining earlier age at diagnosis among relatives as a cohort eff ect ( 14, 21 ) . While previous studies have typically made comparisons between family members from diff erent generations, thereby introducing possible cohort eff ects, we found a modifying eff ect of age both within generations (siblings) and between generations (parent/off spring). Age-stratifi ed absolute risks were also increased. Furthermore, our sensitivity analysis of age-stratifi ed sibling estimates was not aff ected by the exclusion of persons born before 1972, supporting that the eff ect is not a result of incomplete registration. Th us, future preventive studies most likely could increase accuracy when identifying at-risk IBD relatives by taking age into account. While our assessment of second-degree family members allowed for reliable overall estimates, the power to evaluate the modifying eff ect of age among second-degree relatives was low.
Familial risk estimates are the concatenation of genetic and environmental factors (22) (23) (24) . Th e cross correlations between the two diseases observed in the present study support the fi nding from recent genome-wide association study that CD and UC share a number of genes ( 4 ). As to the higher ratio of IBD in the younger age groups, the eff ect could be partly or purely social, a result of shorter patient delay or the eff ect of shared environment including shared gut microbiota ( 25 ) , diet, and smoking habits ( 23 ) . Indeed signifi cantly altered microbial patterns have been found in newly diagnosed IBD patients in a recent study ( 5 ) . As any non-genetic familial risk is potentially reversible, without tangling with the genome, this indeed holds promise for risk reduction and eff ective prevention in the years to come.
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